BEBPA US 2020 Virtual Booth
- May 13, 2020–Jun 30, 2020
Like you, we're sorry this live event was canceled. However, you don't have to lose out on the latest information on our functional bioassays for biologic drug discovery. Our virtual booth has all the highlights that you would have seen at the show!
Don't worry--you won't miss a thing from our posters that were due to be presented at BEBPA US 2020. Our scientists present their results in these poster videos. You can also download a PDF version to review later.
Developing a Bioluminescent PBMC ADCC Assay for the Discovery and Characterization of Therapeutic Antibodies
Presented by Jey Cheng, Sr. Research Scientist
Quantitative Cell-Based Bioassays to Advance Immunotherapy Programs Targeting Immune Checkpoint Receptors
Presented by Jamison Grailer, Sr. Research Scientist
Replace conventional immunoassays, such as Western blots and ELISAs, with new Lumit™ Immunoassays. These assays offer direct luminescence measurement in cell culture, broad dynamic range, and can be completed in as little as 30 minutes.
Lumit™ Immunoassays are available for a range of applications, including protein phosphorylation and pathway analysis, FcRn binding, cytokine detection, metabolite research, and more. You can also build your own Lumit™ immunoassays with our labeling and detection kits.
Biologics Forum: Tips and Tools for Successful Immunotherapy Bioassay Development
Mechanism of action (MOA)-based bioassays are a critical component of biologics drug development. However, establishing a functional bioassay that meets the regulatory guidelines for use in potency determination and lot release can be challenging. Join our panel of bioassay experts for a discussion on bioassay design and selection, assay optimization, and bioassay qualification for potency lot release.
This webinar was originally presented in April 2019 and is being rebroadcast by popular demand.
Date: Wednesday, April 22, 2020
Time: 11:00 am CDT (12:00 pm EDT)
Choosing a Bioactivity Assay
This webinar from Charles River Labs discusses their bioassay development and optimization workflow.
Bioassays Power Combination Immunotherapy
Read our GEN tutorial to learn how reporter bioassays can accelerate combination immunotherapy research.
Measuring ADCC and CDC Activity of Anti-TNFα and Anti-VEGF Therapeutic mAbs
Learn how reporter bioassays and cell health assays are used to measure Fc effector activity.